Health & Nutrition

bg
No prison yet for Elizabeth Holmes following last-ditch appeal

No prison yet for Elizabeth Holmes following last-ditch...

Theranos founder Elizabeth Holmes has appealed a judge's ruling that she report...

bg
Eli Lilly misses on earnings but raises full-year guidance

Eli Lilly misses on earnings but raises full-year guidance

The company reported adjusted earnings of $1.62, which missed analyst expectations...

bg
Dr. Greger’s Top Takeaways on Dietary Cholesterol, Fasting for Cancer, and Edibles

Dr. Greger’s Top Takeaways on Dietary Cholesterol, Fasting...

Every month, we publish around eight new videos, four Friday Favorites, eight blogs,...

bg
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says

Biogen isn't concerned about competing with Eli Lilly in...

Biogen CEO Christopher Viehbacher said during an earnings call that Eli Lilly needs...

bg
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease

FDA grants accelerated approval for Biogen ALS drug that...

The FDA's approval requires Biogen to further study its ALS drug tofersen to further...

bg
Illumina unveils plans to cut costs as it faces shrinking margins

Illumina unveils plans to cut costs as it faces shrinking...

The plans aim to reduce Illumina's annualized run rate expenses by more than $100...

bg
Mpox outbreak was wake-up call for smallpox preparation, vaccine maker Bavarian Nordic says

Mpox outbreak was wake-up call for smallpox preparation,...

Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare...

bg
Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO

Johnson & Johnson to price shares of consumer spinoff Kenvue...

J&J said it launched a roadshow for Kenvue's IPO of more than 151 million shares...

bg
Are Dates Good for Colon Health?

Are Dates Good for Colon Health?

Seven dates a day for three weeks are put to the test in a randomized controlled...

bg
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says

Johnson & Johnson consumer health unit valued at $40 billion...

J&J's consumer health unit Kenvue aims to raise $3.5 billion or more in the...